Robert Donati, PT | |
801 Middleford Rd, Seaford, DE 19973-3636 | |
(302) 629-6224 | |
(302) 629-3504 |
Full Name | Robert Donati |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 30 Years |
Location | 801 Middleford Rd, Seaford, Delaware |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568406189 | NPI | - | NPPES |
1568406189 | Medicaid | DE | |
P00359626 | Other | RAILROAD MEDICARE | |
000093855 | Other | DPCI | |
3739250000 | Other | DE | IBC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | J10001191 (Delaware) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Syracuse Physical Therapy Partners | 6103910948 | 14 |
News Archive
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States.
Men who walked at a fast pace prior to a prostate cancer diagnosis had more regularly shaped blood vessels in their prostate tumors compared with men who walked slowly, providing a potential explanation for why exercise is linked to improved outcomes for men with prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.
Human Genome Sciences, Inc. today announced that Novartis has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) for approval to market JOULFERON® (albinterferon alfa-2b, known in the United States as ZALBIN™) for the treatment of chronic hepatitis C. In November 2009, HGS submitted a Biologics License Application (BLA) for ZALBIN to the FDA in the United States.
Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new treatments, according to late-breaking results from the STAMPEDE trial presented at the ESMO 2017 Congress in Madrid.
› Verified 7 days ago
Provider Name | Syracuse Physical Therapy Partners |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1417160490 PECOS PAC ID: 6103910948 Enrollment ID: O20070924000496 |
News Archive
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States.
Men who walked at a fast pace prior to a prostate cancer diagnosis had more regularly shaped blood vessels in their prostate tumors compared with men who walked slowly, providing a potential explanation for why exercise is linked to improved outcomes for men with prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.
Human Genome Sciences, Inc. today announced that Novartis has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) for approval to market JOULFERON® (albinterferon alfa-2b, known in the United States as ZALBIN™) for the treatment of chronic hepatitis C. In November 2009, HGS submitted a Biologics License Application (BLA) for ZALBIN to the FDA in the United States.
Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new treatments, according to late-breaking results from the STAMPEDE trial presented at the ESMO 2017 Congress in Madrid.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Robert Donati, PT 801 Middleford Rd, Seaford, DE 19973-3636 Ph: (302) 629-6224 | Robert Donati, PT 801 Middleford Rd, Seaford, DE 19973-3636 Ph: (302) 629-6224 |
News Archive
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States.
Men who walked at a fast pace prior to a prostate cancer diagnosis had more regularly shaped blood vessels in their prostate tumors compared with men who walked slowly, providing a potential explanation for why exercise is linked to improved outcomes for men with prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.
Human Genome Sciences, Inc. today announced that Novartis has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) for approval to market JOULFERON® (albinterferon alfa-2b, known in the United States as ZALBIN™) for the treatment of chronic hepatitis C. In November 2009, HGS submitted a Biologics License Application (BLA) for ZALBIN to the FDA in the United States.
Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new treatments, according to late-breaking results from the STAMPEDE trial presented at the ESMO 2017 Congress in Madrid.
› Verified 7 days ago
Richard Sullivan, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22830 & 22832 Sussex Highway, Suite 13 & 14, Seaford, DE 19973 Phone: 302-536-5562 Fax: 302-628-5313 | |
Ms. Hannah Rae Porter, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 808 Middleford Rd, Seaford, DE 19973 Phone: 302-629-4024 Fax: 302-629-6371 | |
Nicholas Elliot Galeone, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 Fallon Ave, Seaford, DE 19973 Phone: 302-536-1774 Fax: 302-536-7096 | |
Clement Raymond Tajon, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Middleford Rd, Seaford, DE 19973 Phone: 302-629-6611 | |
Ekta Sharma, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 715 King Street, Lofland Park Center, Seaford, DE 19973 Phone: 302-628-3000 | |
Mr. Percival Corpuz Jr., Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 715 E King St, Seaford, DE 19973 Phone: 610-925-4148 Fax: 610-347-4948 | |
Genevieve Luzano, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1310 Middleford Rd Ste 101, Seaford, DE 19973 Phone: 919-258-2714 Fax: 410-648-4878 |